Scientists discover promising new lead in Crohn's disease


QIMR Berghofer researchers have identified a key driver of the aggressive gut disorder, Crohn’s disease, a finding that could eventually lead to new treatments for the often-debilitating condition.

Crohn’s disease – also known as inflammatory bowel disease – is incurable and affects about 35,000 people in Australia.

QIMR Berghofer scientists found the protein PD-L2 was overactive in people with Crohn’s disease.

The study was led by the head of the Molecular Immunology group, Dr Michelle Wykes, and Dr Graham Radford-Smith, who leads the Institute’s Gut Health Laboratory and is a Deputy Director at the Royal Brisbane and Women’s Hospital (RBWH) Department of Gastroenterology.

PD-L2 acts as a gatekeeper molecule in the body’s immune cells, deciding if other molecules in the cells should react to a threat.

Dr Wykes said her previous work examining the role PD-L2 played in diseases such as cancer and malaria led her to look at the part it played in Crohn’s disease.

“Our past studies showed the PD-L2 protein was missing in the blood and tissue of cancer and malaria patients. This meant that other inflammation-suppressing molecules weren’t being controlled, so they were suppressing the immune system too much,” Dr Wykes said.

“That’s when we asked ourselves if the opposite was the case in Crohn’s disease, which is characterised by excessive inflammation.

“And that’s exactly what we found – that there was an excess of these PD-L2 “gatekeeper” proteins in the blood of Crohn’s patients. This overabundance was obviously stopping other molecules from doing their jobs in suppressing inflammation.

“This was something that no one else had thought to look for, or had looked at in the same way.”

The researchers examined blood and tissue samples from 29 patients who had been treated for Crohn’s disease at the RBWH.

Lab testing showed that if antibodies that control PD-L2 were introduced to Crohn’s disease cells from patients, then inflammation could be slowed down.

Dr Radford-Smith said the study results could provide scientists with a new target for potential treatments.

“Crohn’s disease is a chronic inflammatory disorder where the body appears to be generating its own inflammation against itself, and that’s one of the reasons why the role of the “gatekeeper” molecule PD-L2 is so relevant,” Dr Radford-Smith said.

“This study is another important step in our understanding of Crohn’s disease and opens up a new area to investigate.

“If we can understand why inflammation occurs in Crohn’s patients, then we can work out strategies to treat, and possibly in the future, prevent the disease.”

The study found there were also fewer immune-controlling dendritic cells in the lining of the guts of people with Crohn’s disease.

“Our priority now is to try to secure funding to extend this research using a much larger group of patients to really test this new and important finding,” Dr Wykes said.

“Understanding inflammation in Crohn’s will also add to our growing bank of knowledge that inflammation is a factor in many diseases.

“This is just the start. We believe that understanding this protein will have big implications for a range of autoimmune conditions.”

The study findings have been published in the journal Clinical and Translational Immunology.

The research was funded through donations to QIMR Berghofer Medical Research Institute.

Community Health & Wellness Science & Research

QIMR Berghofer Medical Research Institute :
PO Royal Brisbane Hospital, Brisbane, QLD, 4029, Brisbane
07 3845 3752
QIMR Berghofer Medical Research Institute
Showing 10+ recent articles for this business
Australian researchers recruit for world's largest skin cancer study 17 September 2019 | Queensland researchers have launched the world’s largest ever genetic study of skin cancer and are calling on more than 20,000 Australians to take part. More information...
Scientists discover promising new lead in Crohn's disease 17 September 2019 | QIMR Berghofer researchers have identified a key driver of the aggressive gut disorder, Crohn’s disease, a finding that could eventually lead to new treatments for the often-debilitating condition. More information...
Australian researchers find 45 new genetic causes of non-melanoma skin cancers 06 August 2019 | An Australian study has discovered 45 new genetic variants that put people at a greater risk of developing the most common form of skin cancers, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). More information...
Daily coffee doesn’t affect cancer risk 18 July 2019 | Drinking coffee does not change a person’s risk of being diagnosed with or dying from cancer, a new QIMR Berghofer study has found. More information...
Australian researchers help identify first genes linked to anorexia nervosa 16 July 2019 | QIMR Berghofer researchers have played a vital role in helping identify the first eight genes associated with the eating disorder anorexia nervosa. More information...
Being born prematurely changes sleep brain activity and could affect future brain heath 26 June 2019 | A new study has shed light on how being born extremely early can change an infant’s brain activity during sleep, with flow-on effects for brain development two years later. More information...
More genetic evidence of what puts people at risk of breast and other cancers 18 June 2019 | A new international study has discovered that 94 genetic variants, about which little has been known until now, increase a person’s risk of developing breast, ovarian, prostate and pancreatic cancers. More information...
Chronic liver disease on the rise in Queensland 13 June 2019 | A new study by QIMR Berghofer and Princess Alexandra Hospital has found a significant increase in the number of Queenslanders being admitted to hospital for treatment of chronic liver disease, and the rates are... More information...
Australian pilots not at higher risk of Melanoma 21 May 2019 | A new study has found modern airline pilots registered in Australia, appear not to be at higher risk of developing invasive melanoma than the rest of the population. More information...
Study finds being overweight is likely to cause cancer 16 May 2019 | A QIMR Berghofer study has found people who are overweight could reduce their risk of dying from cancer later in life by up to 30 per cent, by shedding some kilograms and maintaining a healthy body mass index... More information...

comments powered by Disqus

All articles submitted by third parties or written by My Sunshine Coast come under our Disclaimer / Terms of Service